Americas
2 January 2026 With the unprecedented changes at the PTAB in 2025, what could the year ahead hold for the agency? Lawyers from Sterne Kessler explore.
29 December 2025
24 December 2025
22 December 2025
17 December 2025
15 December 2025
Latest Features
Americas
Companies that integrate data rights into their IP strategy with a holistic approach will lead in innovation while minimising risk, says Terri Shieh-Newton of Mintz.
Americas
In the complex world of bsAb patenting, counsel need to turn chefs to serve up success. Benjamin Pelletier of Haynes Boone puts together a menu of dos and don’ts.
Americas
The USPTO’s ‘settled expectations’ rule is anything but settled, argues Andrew Zappia of Troutman Pepper Locke.
Americas
In the second of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax delve into the real reasons why medicine costs more in the US.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Americas
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones.
Americas
Brazil’s updated regulations for its flagship partnerships programme marks a renewed effort to strengthen the nation's health sector, says Rob Rodrigues of RNA Law.
Americas
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares.
More News
11 December 2025 Israeli drug maker bows to FTC pressure, removing scores of “improperly listed” patents in boon for generic manufacturers.
9 December 2025 New hires bring “exceptional technical expertise” and a strong track record across biotechnology and pharmaceutical patent matters.
8 December 2025 As part of a broader bid to remove obstacles to patents, director Squires clarifies how examiners, applicants and practitioners may handle patent subject matter eligibility rejections.
5 December 2025 A Finnish wearable fitness gadget company has lost its bid to overturn the invalidation of a key patent, with the US Federal Circuit affirming it is abstract under Alice.
3 December 2025 The appeals court reversed a jury verdict, finding the antibody-drug conjugate patent lacked adequate written description and enablement support from its priority application.
3 December 2025 The firm has hired a former chemical engineer with clients in aviation, medical devices, and industrial manufacturing, who also led Kilpatrick’s patent best practices committee.
27 November 2025 Director Squires rescinds previous guidelines and clarifies that there is no separate, modified inventorship standard for AI-assisted inventions.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox